Area of research
Complementary and alternative medicine · Oncology
Research interest
Research focused on Plerixafor and TCF4, with related work in CXCR4, Autoimmune lymphoproliferative syndrome, Bromodomain. Notable publications include 'A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm', 'A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor', and 'Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans'.
Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells
A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm
A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor
Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans